destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
Published 6 months ago • 276 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
3:15
dr curigliano on the efficacy of t-dxd in her2-low and her2-ultralow breast cancer
-
7:12
t-dxd demonstrates high levels of efficacy in patients with her2 unresectable and/or mbc previo...
-
3:09
destiny-breast02: high levels of efficacy of t-dxd in previously treated her2 breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
1:06
incorporating t-dxd in patients with her2 or her2-low bc and leptomeningeal carcinomatosis
-
2:02
dr tarantino on updated survival data with t-dxd in her2 breast cancer
-
1:05
efficacy of trastuzumab deruxtecan in her2-low metastatic breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
2:59
talent: neoadjuvant t-dxd with or without anastrozole for her2-low, hr early stage breast cancer
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
1:09
the exciting new field of her2-low breast cancer
-
3:36
trastuzumab deruxtecan in patients with breast cancer and brain metastases in destiny-breast01